A collaborative interdisciplinary team has designed a full sized humanoid bipedal robot.
The robot has already been integrated into a contemporary Korean dance performance.
The next step say developers is to develop the upper body.
Let's see minimum wagers compete with this
(via DHRC)
Germany poised to say yes to €1.1m a patient gene therapy drug
ReplyDeleteAlthough there is already a gene therapy for cancer on the market in China, that has not been rolled out to other countries, making Glybera a first for the west.
Proponents of the gene-fixing technology insist it stacks up as a cost-effective treatment, despite the high cost, as it could permanently cure many patients.
http://www.theguardian.com/society/2014/nov/27/worlds-most-expensive-medicine-glybera-sale-1million-price
can't wait til they displace all those pharm sale reps hawking poison.